Griffon Corporation (GFF)
NYSE: GFF · Real-Time Price · USD
67.97
-3.05 (-4.29%)
Aug 7, 2025, 4:00 PM - Market closed
Longboard Pharmaceuticals Stock Forecast
Stock Price Forecast
The 4 analysts that cover Longboard Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $99, which forecasts a 45.65% increase in the stock price over the next year. The lowest target is $91 and the highest is $105.
Price Target: $99.00 (+45.65%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Longboard Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy Maintains $92 → $100 | Buy | Maintains | $92 → $100 | +47.12% | Jul 22, 2025 |
| Raymond James | Raymond James | Strong Buy Reiterates $95 → $100 | Strong Buy | Reiterates | $95 → $100 | +47.12% | May 9, 2025 |
| Deutsche Bank | Deutsche Bank | Strong Buy Initiates $91 | Strong Buy | Initiates | $91 | +33.88% | Apr 1, 2025 |
| Raymond James | Raymond James | Strong Buy Reiterates $92 → $95 | Strong Buy | Reiterates | $92 → $95 | +39.77% | Feb 6, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $100 → $105 | Buy | Maintains | $100 → $105 | +54.48% | Feb 6, 2025 |
Financial Forecast
Revenue This Year
2.58B
from 2.62B
Decreased by -1.54%
Revenue Next Year
2.66B
from 2.58B
Increased by 3.06%
EPS This Year
5.77
from 4.23
Increased by 36.34%
EPS Next Year
6.42
from 5.77
Increased by 11.38%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 2.7B | 2.8B | 2.9B |
| Avg | 2.6B | 2.7B | 2.7B |
| Low | 2.5B | 2.6B | 2.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 3.1% | 8.7% | 7.3% |
| Avg | -1.5% | 3.1% | 2.1% |
| Low | -5.1% | -1.2% | -2.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 6.09 | 7.21 | 8.40 |
| Avg | 5.77 | 6.42 | 7.83 |
| Low | 5.44 | 5.66 | 7.35 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 44.0% | 25.1% | 30.8% |
| Avg | 36.3% | 11.4% | 21.9% |
| Low | 28.6% | -1.8% | 14.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.